Sbi Securities Co., Ltd. Equillium, Inc. Transaction History
Sbi Securities Co., Ltd.
- $3.25 Trillion
- Q4 2024
A detailed history of Sbi Securities Co., Ltd. transactions in Equillium, Inc. stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 765 shares of EQ stock, worth $696. This represents 0.0% of its overall portfolio holdings.
Number of Shares
765Holding current value
$696% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding EQ
# of Institutions
28Shares Held
11.3MCall Options Held
0Put Options Held
0-
Decheng Capital Management Iii (Cayman), LLC4.45MShares$4.05 Million1.82% of portfolio
-
Decheng Capital LLC Menlo Park, CA4.45MShares$4.05 Million0.88% of portfolio
-
Vanguard Group Inc Valley Forge, PA842KShares$766,1720.0% of portfolio
-
Cota Capital Management, LLC San Francisco, CA562KShares$511,6721.86% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny321KShares$292,2670.0% of portfolio
About Equillium, Inc.
- Ticker EQ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,352,100
- Market Cap $31.3M
- Description
- Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which i...